
Mark Lister: Is market's bull run over?
We're unlikely to get a repeat of the New Zealand sharemarket's exceptional year, predicts Mark Lister.
We're unlikely to get a repeat of the New Zealand sharemarket's exceptional year, predicts Mark Lister.
Shares in Pyne Gould Corp plunged to a record low after yesterday's annual meeting in Auckland.
Tower has posted a 67 per cent jump in full-year profit and said it will return $120 million to shareholders.
Shares in Pharmacybrands rallied to a three-week high after the rcompany lifted first-half profit 52 per cent.
Fonterra said it had set its final price for units in the Fonterra Shareholders' Fund at $5.50 per unit - the top end of an indicative $4.60 to $5.50 range.
An accountant's blunder in the 2009 accounts of New Zealand Farming Systems Uruguay has come back to haunt a Singaporean commodities giant.
New Zealand's mostly Australian-owned banks are not as profitable as they appear, despite very strong earnings, the NZ Bankers Association says.
Distribution and logistics centres in the spotlight as firm looks to save money.
Chinese interest in investing in Fonterra's Cooperative Group's shareholder fund was predictable, says the main farm lobby group.
New Zealand has outshone the world's major economies to top a Forbes list of the best countries for business.
The gender pay gap is the biggest it has been in 10 years, according to new data from Statistic New Zealand.
See a replay of our live chat with ANZ rural economist Con Williams on Fonterra's TAF scheme and the dairy industry.
Rakon will cut up to 60 New Zealand jobs as it shifts more manufacturing to China and India in a bid to cut costs and widen profit margins.